HomeNDC LookupIngredientsMeclizine Hydrocloride › 68071-3017-09
image loading
(from DailyMed)

MECLIZINE HYDROCHLORIDE Meclizine Hydrocloride 25 mg Tablet, 90-count

by NuCare Pharmaceuticals,Inc. · 90 TABLET in 1 BOTTLE (68071-3017-9)
NDC 68071-3017-09
🏷️ FDA NDC (as labeled) 68071-3017-9 billing pads the package segment with a zero
This package
Contains90-count Pack sizes6 compare ↓
Also priced by: Part D plans $0.1168/unit — full pricing hub ↓
Rx only Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 68071-3017-9
Product NDC 68071-3017
11-digit billing NDC 68071301709
RxCUI 995666
UNII HDP7W44CIO
UPC 0368071301731
Application # ANDA040659
SPL Set ID 64a508ae-768a-2fba-e053-2991aa0ac42d
Established class (EPC) Antiemetic
Physiologic effect Emesis Suppression
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-06-04
Route ORAL
Dosage form TABLET
Substance MECLIZINE HYDROCHLORIDE
TE code (Orange Book) AA · RLD · RS
Why two NDCs? The FDA registers this code as 68071-3017-9 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 68071-3017-09. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Antiemetic class.

Pharmacologic class Antiemetic
Drug family (ATC) Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerNuCare Pharmaceuticals,Inc.
Application holderJUBILANT CADISTA PHARMACEUTICALS INC
FDA applicationANDA040659 (ANDA)
Labeler code68071
First marketedJun 2010
Product typeHuman Prescription Drug
Portfolio1,015 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
  • For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
  • Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
  • This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
📖 Read our full Meclizine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.1168 $10.51 / 90 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Meclizine Hydrochloride 25 mg 00904-7376-61 Major 100 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 16571-0661-01 Rising 100 tablets $0.078 Availability likely
Meclizine Hydrochloride 25 mg 42806-0014-01 Epic 100 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 50268-0523-15 AvPAK 50 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 53746-0442-01 Amneal 100 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 59651-0808-01 Aurobindo 100 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 60687-0730-01 American 100 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 62135-0953-90 Chartwell 90 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 70710-1162-00 Zydus 1000 tablets $0.078 AA Availability likely
Meclizine Hydrochloride 25 mg 59746-0121-06 Jubilant 100 tablets $0.080 AA Availability likely
Meclizine Hydrochloride 25 mg 24689-0139-01 APNAR 100 tablets $0.134 Availability likely
Meclizine Hydrochloride 25 mg 24689-0146-01 APNAR 100 tablets $0.134 Availability likely
Motion Sickness Relief 25 mg 46122-0535-51 Amerisource 8 tablets $0.134 Availability likely
Motion Sickness Relief 25 mg 70000-0097-01 Cardinal 32 tablets $0.134 Availability likely
Motion Sickness 25 mg 70677-1088-01 Strategic 8 tablets $0.134 Availability likely
Motion Sickness Relief 25 mg 00363-4030-21 Walgreen 16 tablets FDA listed
Meclizine Hydrochloride 25 mg 00615-8515-39 NCS 30 tablets AA FDA listed
PhysiciansCare Motion Sickness 25 mg 00924-1008-00 Acme 2 tablets FDA listed
Motion Sickness Relief 25 mg 11673-0356-08 TARGET 8 tablets FDA listed
Less Drowsy Motion Sickness Relief 25 mg 11822-0775-09 Rite 8 tablets FDA listed
Motion Sickness Relief Less Drowsy 25 mg 21130-0778-02 Better 12 tablets FDA listed
Motion Sickness Relief 25 mg 30142-0943-19 Kroger 8 tablets FDA listed
Motion Sickness Relief 25 mg 36800-0943-19 Topco 8 tablets FDA listed
Motion Sickness 25 mg 37808-0903-12 H 100 tablets FDA listed
Motion Sickness Relief 25 mg 41163-0304-02 United 12 tablets FDA listed
Motion Sickness Relief 25 mg 41250-0930-19 Meijer 8 tablets FDA listed
Meclizine Hydrocloride 25 mg 42708-0102-30 QPharma 30 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 42708-0127-30 QPharma 30 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 42708-0189-30 QPharma 30 tablets AA FDA listed
Medique Medi-Meclizine 25 mg 47682-0481-15 Unifirst 1000 tablets FDA listed
Less Drowsy Motion Sickness Relief 25 mg 49035-0403-19 Wal-Mart 8 tablets FDA listed
Meclizine Hydrochloride 25 mg 50090-5727-02 A-S 12 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 50090-5728-00 A-S 20 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 50090-7416-02 A-S 12 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 50090-7417-00 A-S 20 tablets AA FDA listed
Dramamine Less Drowsy Meclizine Hydrochloride 25 mg 50269-0526-00 JC 40 tablets FDA listed
Motion Sickness Relief 25 mg 50844-0403-19 L.N.K. 8 tablets FDA listed
Meclizine Hydrochloride 25 mg 51655-0107-20 Northwind 20 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 51655-0175-52 Northwind 30 tablets AA FDA listed
Motion Sickness 25 mg 55301-0403-21 ARMY 16 tablets FDA listed
Motion Sickness Relief 25 mg 55319-0903-19 Family 8 tablets FDA listed
Motion Sickness Relief 25 mg 55910-0943-19 DOLGENCORP, 8 tablets FDA listed
Less Drowsy Formula Motion Sickness Relief 25 mg 57243-0403-02 Salado 12 tablets FDA listed
Travel-Ease 25 mg 57896-0378-01 Geri-Care 100 tablets FDA listed
Meclizine Hydrochloride 25 mg 60760-0661-30 St. 30 tablets FDA listed
Dramamine Less Drowsy 25 mg 63029-0903-01 Medtech 8 tablets FDA listed
Dramamine - N 25 mg 63029-0905-10 Medtech 10 tablets FDA listed
Meclizine Hydrochloride 25 mg 63187-0258-10 Proficient 10 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 63187-0996-10 Proficient 10 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 65162-0442-03 Amneal 30 tablets AA FDA listed
Dramamine Less Drowsy, Lil Drug Store 25 mg 66715-9734-01 Lil' 2 tablets FDA listed
Meclizine Hydrochloride 25 mg 67296-2138-02 Redpharm 21 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 67296-2205-02 Redpharm 21 tablets AA FDA listed
Dramamine Less Drowsy 25 mg 67751-0242-02 Navajo 2 tablets FDA listed
Meclizine Hydrochloride 25 mg 68071-2380-02 NuCare 20 tablets FDA listed
Meclizine Hydrochloride 25 mg 68071-2416-06 NuCare 6 tablets FDA listed
Meclizine Hydrochloride 25 mgthis 68071-3017-09 NuCare 90 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 68071-3748-04 NuCare 4 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 68071-3791-02 NuCare 20 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 69842-0857-05 CVS 16 tablets FDA listed
Meclizine Hydrochloride 25 mg 70518-1308-00 REMEDYREPACK 90 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 70518-3815-00 REMEDYREPACK 21 tablets Discontinued
Meclizine Hydrochloride 25 mg 70771-1540-00 Zydus 1000 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 71205-0786-10 Proficient 10 tablets FDA listed
Meclizine Hydrochloride 25 mg 71335-0503-00 Bryant 14 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 71335-1825-00 Bryant 14 tablets FDA listed
Meclizine Hydrochloride 25 mg 72189-0237-30 Direct_Rx 30 tablets Discontinued
Meclizine Hydrochloride 25 mg 76420-0130-10 Asclemed 10 tablets AA FDA listed
Meclizine Hydrochloride 25 mg 76420-0798-01 Asclemed 100 tablets FDA listed
Nausea Relief 25 mg 79903-0177-10 WALMART 10 tablets FDA listed
Meclizine Hydrochloride 25 mg 80425-0494-01 Advanced 30 tablets FDA listed
Meclizine Hydrochloride 25 mg 82868-0058-20 Northwind 20 tablets AA FDA listed
Motion Sickness Relief 25 mg 83059-0007-01 Shield 15 tablets FDA listed
Pepto Nausea Motion Sickness 25 mg 84126-0340-01 THE 10 tablets FDA listed
Medique Medi-Meclizine 25 mg 85766-0175-00 Sportpharm 1000 tablets FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2010
On the market since
Jun 2010
📍
2026
Currently FDA-listed
16 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Meclizine Hydrochloride (this brand).

Top reported reactions

Dizziness1,631
Nausea1,420
Fatigue1,369
Headache1,059
Diarrhoea1,047
Pain1,008
Fall997

Age at onset

Neonate22
Child1
Adolescent16
Adult1,197
Elderly1,492

Reporter sex

16,229 reports
Male · 26%
Female · 74%
Unknown · 0%
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 1,154 565
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
68071-3017-01 12 TABLET in 1 BOTTLE (68071-3017-1) 2018-02-07 Active
68071-3017-02 20 TABLET in 1 BOTTLE (68071-3017-2) 2018-02-07 Active
68071-3017-03 30 TABLET in 1 BOTTLE (68071-3017-3) 2018-02-07 Active
68071-3017-06 60 TABLET in 1 BOTTLE (68071-3017-6) 2018-02-07 Active
68071-3017-07 10 TABLET in 1 BOTTLE (68071-3017-7) 2018-02-07 Active
68071-3017-09 You're viewing this 90 TABLET in 1 BOTTLE (68071-3017-9) 2018-02-07 Active

You're viewing the largest of 6 pack sizes for this product.

Pack size FAQ

What quantity is in NDC 68071-3017-09?
NDC 68071-3017-09 is a 90-count package — 90 tablet in 1 bottle.
What is the difference between NDC 68071-3017-09 and NDC 68071-3017-07?
Both are MECLIZINE HYDROCHLORIDE Meclizine Hydrocloride 25 mg Tablet — the drug itself is identical. NDC 68071-3017-09 is the 90-count package, while NDC 68071-3017-07 is the 10 tablets package.
What NDC number is used to bill for this package of MECLIZINE HYDROCHLORIDE Meclizine Hydrocloride 25 mg Tablet?
Bill NDC 68071-3017-09 — the 11-digit billing format is 68071301709. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 68071-3017-9, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 68071-3017-09, written without dashes as 68071301709. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 68071-3017-09, the first segment (68071) is the labeler code FDA assigned to NuCare Pharmaceuticals,Inc.; the middle segment (3017) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (09) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by NuCare Pharmaceuticals,Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 10 tablets (68071-3017-07), 12 tablets (68071-3017-01), 20 tablets (68071-3017-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
NuCare Pharmaceuticals,Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 16 words

INDICATIONS AND USAGE For the management of nausea and vomiting, and dizziness associated with motion sickness.

⏱️ Dosage and Administration 44 words

DOSAGE AND ADMINISTRATION Motion Sickness The initial dose of 25 to 50 mg of Meclizine HCI should be taken one hour prior to travel for protection against motion sickness. Thereafter, the dose may be repeated every 24 hours for the duration of the journey.

Contraindications 15 words

CONTRAINDICATIONS Meclizine Hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it.

⚠️ Warnings 62 words

WARNINGS Since drowsiness may, on occasion, occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery. Patients should avoid alcoholic beverages while taking this drug. Due to its potential anticholinergic action, this drug should be used with caution in patients with asthma, glaucoma or enlargement of the prostate gland.

🤒 Adverse Reactions 14 words

ADVERSE REACTIONS Drowsiness, dry mouth and, on rare occasions, blurred vision have been reported.

🧬 Clinical Pharmacology 62 words

CLINICAL PHARMACOLOGY Meclizine Hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs. It has a marked effect in blocking the vasodepressor response to histamine, but only a slight blocking action against acetylcholine. Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum.

📦 How Supplied / Storage and Handling 61 words

HOW SUPPLIED 25 mg (Yellow, oval-shaped, scored, debossed with TL121) NDC 68071-3017-7 BOTTLES OF 10 NDC 68071-3017-1 BOTTLES OF 12 NDC 68071-3017-2 BOTTLES OF 20 NDC 68071-3017-3 BOTTLES OF 30 NDC 68071-3017-6 BOTTLES OF 60 NDC 68071-3017-9 BOTTLES OF 90 Store at 20-25°C (68-77°F) (See USP Controlled Room Temperature]. Manufactured By: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA. Revised 03/11

📋 Description 99 words

DESCRIPTION Chemically, Meclizine HCl is 1-( p -chloro-α-phenylbenzyl)-4-( m -methylbenzyl) piperazine dihydrochloride monohydrate. C 25 H 27 ClN 2 . 2HCl .

H 2 O M . W . 481 .

88 Meclizine HCI Tablets, USP are available in two different strengths: 12.5 mg and 25 mg. In addition each tablet contains the following inactive ingredients: Colloidal Silicon Dioxide, Croscarmellose Sodium, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose. Also, Meclizine HCI Tablets USP, 12.5 mg contains FD&C Blue #1 Aluminum Lake (11-13%) and Meclizine HCI Tablets USP, 25 mg contains D&C Yellow #10 Aluminum Lake (15-20%).

Structure of Meclizine HCl

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.